7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 
      
                    
      cash flows from operating activities:
                    
      net income
    -4,680,000 -1,739,000 -1,304,000 -21,900,000 -29,959,000 -20,184,000 -23,325,000 -28,081,000 -31,033,000 -35,658,000 -42,664,000 -55,477,000 -57,843,000 -69,753,000 -49,059,000 -74,736,000 
      adjustments to reconcile net income to net cash from operating activities:
                    
      depreciation and amortization
    6,604,000 6,281,000 6,360,000 6,363,000 6,339,000 3,746,000 2,967,000 3,046,000 2,984,000 3,002,000 3,112,000 2,930,000 2,795,000 2,806,000 2,973,000 3,502,000 
      amortization of deferred contract acquisition costs
    7,987,000 7,848,000 7,583,000 7,889,000 7,129,000 6,886,000 6,652,000 6,365,000 6,131,000 5,852,000 5,617,000 5,211,000 4,625,000 4,421,000 4,275,000 3,759,000 
      non-cash lease expense
    2,392,000 2,320,000 2,303,000 2,235,000 2,208,000 2,419,000 1,980,000 2,044,000 1,965,000 1,877,000 1,850,000 1,732,000 1,567,000 1,492,000 1,404,000  
      stock-based compensation
    48,529,000 49,280,000 51,664,000 50,416,000 58,709,000 55,139,000 52,442,000 50,640,000 55,125,000 54,248,000 50,694,000 57,044,000 53,892,000 50,135,000 46,625,000 49,184,000 
      discount amortization on marketable securities
    -1,822,000 -1,793,000 -1,901,000  -4,251,000 -4,098,000 -4,623,000          
      gain on sale of non-marketable equity investments
                    
      deferred income taxes
    -459,000 1,159,000 -14,278,000 477,000 -1,435,000 113,000 -2,714,000 309,000 9,814,000 
      other
    247,000 487,000 -17,000 1,076,000 552,000 -145,000 -86,000 34,000 123,000 -33,000 85,000 -581,000 273,000 441,000 754,000 -161,000 
      changes in operating assets and liabilities:
                    
      accounts receivable
    -3,954,000 -3,613,000 10,594,000 -23,747,000 1,654,000 -7,902,000 12,850,000 -16,979,000 -6,404,000 -1,109,000 -2,490,000 -13,636,000 -1,432,000 -6,984,000 3,160,000 -7,470,000 
      deferred contract acquisition costs
    -10,603,000 -10,054,000 -8,704,000 -9,819,000 -7,803,000 -9,830,000 -7,072,000 -7,815,000 -6,391,000 -7,188,000 -5,568,000 -9,006,000 -6,913,000 -7,041,000 -5,600,000 -7,186,000 
      prepaid expenses and other assets
    7,316,000 -7,372,000 -15,317,000 6,340,000 -557,000 -567,000 -6,609,000 4,382,000 -5,222,000 677,000 -7,248,000 4,233,000 -3,929,000 240,000 -8,685,000 8,881,000 
      accounts payable
    2,317,000 2,754,000 526,000 -5,326,000 -2,859,000 7,949,000 -1,968,000 796,000 1,002,000 -2,727,000 -1,494,000 2,039,000 -2,416,000 2,513,000 -2,059,000 2,528,000 
      accrued and other liabilities
    5,403,000 8,309,000 -496,000 4,266,000 1,315,000 8,628,000 245,000 4,989,000 2,331,000 -5,089,000 -392,000 3,872,000 668,000 8,178,000 -4,972,000 -803,000 
      deferred revenue
    8,870,000 8,390,000 7,049,000 27,849,000 9,740,000 7,711,000 9,508,000 20,314,000 11,727,000 13,808,000 14,924,000 14,657,000 8,173,000 8,384,000 14,239,000 17,014,000 
      operating lease liabilities
    -3,297,000 -2,507,000 92,000 -2,419,000 112,000 862,000 -2,819,000 -3,865,000 -4,135,000 -3,417,000 -1,500,000 -950,000 -3,160,000 -1,987,000 -2,690,000  
      net cash from operating activities
    63,472,000 58,591,000 57,973,000 41,362,000 42,329,000 36,336,000 40,619,000 30,866,000 23,913,000 19,895,000 11,504,000 7,167,000 -4,223,000 -6,824,000 1,355,000 4,844,000 
      capex
    -6,263,000 -5,056,000 -4,068,000 -6,978,000 -2,224,000 -3,514,000 -1,946,000 -2,275,000 -1,842,000 -1,815,000 -2,408,000 -3,129,000 -3,013,000 -3,362,000 -2,741,000 -2,011,000 
      free cash flows
    57,209,000 53,535,000 53,905,000 34,384,000 40,105,000 32,822,000 38,673,000 28,591,000 22,071,000 18,080,000 9,096,000 4,038,000 -7,236,000 -10,186,000 -1,386,000 2,833,000 
      cash flows from investing activities:
                    
      purchases of property and equipment
    -1,792,000 -380,000 -1,296,000 -5,067,000 -1,056,000 -2,315,000 -739,000 -1,079,000 -278,000 -329,000 -383,000 -1,841,000 -1,907,000 -1,984,000 -1,397,000 -1,509,000 
      proceeds from sale of property and equipment
    54,000 2,000 38,000 193,000 23,000 22,000 41,000 19,000 33,000 34,000 24,000 5,000 49,000 66,000 17,000 55,000 
      capitalized internal-use software
    -4,471,000 -4,676,000 -2,772,000 -1,911,000 -1,168,000 -1,199,000 -1,207,000 -1,196,000 -1,564,000 -1,486,000 -2,025,000 -1,288,000 -1,106,000 -1,378,000 -1,344,000 -502,000 
      purchases of marketable securities
    -143,786,000 -225,273,000 -121,933,000 -53,935,000 -173,455,000 -174,302,000 -218,881,000 -189,124,000 -161,261,000 -274,664,000 -217,754,000 -310,059,000 -250,301,000 -136,792,000 -151,408,000 -531,250,000 
      sale of non-marketable equity investments
                    
      maturities and redemptions of marketable securities
    193,555,000 187,485,000 172,194,000 269,868,000 225,806,000 208,975,000 183,015,000 203,599,000 265,214,000 279,245,000 261,474,000 189,430,000 113,055,000 110,820,000 69,750,000 6,576,000 
      business combination, net of cash acquired
                  
      net cash from investing activities
    45,544,000 -42,842,000 46,231,000 209,148,000 50,150,000 -182,724,000 -37,771,000 12,219,000 102,144,000 2,800,000 41,336,000 -123,753,000 -140,210,000 4,782,000 -25,646,000 -432,291,000 
      cash flows from financing activities:
                    
      proceeds from issuance of common stock under employee stock purchase plan
      3,013,000   2,959,000   3,859,000    
      proceeds from exercise of stock options
    12,000 14,000 48,000 50,000 3,000 26,000 10,000 27,000 16,000 39,000 6,000 11,000 2,000 68,000 28,000 51,000 
      payment of withholding taxes on net share settlement of equity awards
    -14,954,000 -13,749,000 -16,711,000 -10,672,000 -11,643,000 -15,020,000 -22,964,000 -16,196,000 -24,045,000 -15,303,000 -12,434,000 -15,508,000 -13,367,000 -18,401,000 -119,948,000  
      repurchase of common stock
    -159,110,000 -113,586,000 -113,610,000              
      net cash from financing activities
    -174,052,000 -124,014,000 -130,273,000 -21,302,000 -11,640,000 -11,364,000 -22,954,000 -13,210,000 -24,029,000 -10,952,000 -12,428,000 -11,638,000 -13,365,000   -4,650,000 
      net decrease in cash, cash equivalents and restricted cash
    -65,036,000 -108,265,000 -26,069,000              
      cash, cash equivalents and restricted cash, beginning of period
    620,405,000 488,216,000 304,158,000 747,864,000 
      cash, cash equivalents and restricted cash, end of period
    -65,036,000 -108,265,000 594,336,000 229,208,000 80,839,000 -157,752,000 468,110,000 29,875,000 102,028,000 11,743,000 344,570,000 -128,224,000 -157,798,000 -13,364,000 603,544,000 -432,097,000 
      reconciliation of cash, cash equivalents and restricted cash to condensed consolidated balance sheets:
                    
      cash and cash equivalents
    -65,036,000 -108,273,000 594,243,000 229,214,000 80,835,000 -157,751,000 468,017,000 29,872,000 102,029,000 11,733,000 344,487,000 -128,230,000 -157,794,000 -13,359,000 603,466,000  
      restricted cash included in prepaid expenses and other current assets
      3,000      3,000 -43,000 46,000  
      restricted cash included in other assets
    11,000 90,000 -6,000 4,000 -4,000 93,000 3,000 -1,000 13,000 80,000 6,000 39,000 -5,000 32,000  
      total cash, cash equivalents and restricted cash
    -65,036,000 -108,265,000 594,336,000 229,208,000 80,839,000 -157,752,000 468,110,000 29,875,000 102,028,000 11,743,000 344,570,000 -128,224,000 -157,798,000 -13,364,000 603,544,000  
      cash flows operating activities:
                    
      discount on amortization on marketable securities
                    
      sales of marketable securities
               34,050,000 58,736,000 94,339,000 
      payment of deferred offering costs
               -109,000 -1,358,000 
      net increase in cash, cash equivalents and restricted cash
       229,208,000 80,839,000 -157,752,000 -20,106,000 29,875,000 102,028,000 11,743,000 40,412,000 -128,224,000 -157,798,000 -13,364,000 -144,320,000 -432,097,000 
      reconciliation of cash, cash equivalents and restricted cash to consolidated balance sheets:
                    
      premium (discount) amortization on marketable securities
           -3,544,000 -4,286,000 -4,302,000 -3,520,000      
      gain realized on sale of marketable securities and non-marketable equity investments
                    
      change in fair value of equity securities
           -25,000 -4,000 -46,000 -15,000 4,000 10,000 -85,000 -32,000 
      sale of non-marketable equity investment
                   
      proceeds from initial public offering, net of underwriting discounts
                   
      payment of acquisition-related liabilities
                   
      acquired intangible assets
                    
      premium amortization on marketable securities
                -533,000 331,000 766,000  
      gain realized on sale of marketable securities and non-marketable equity investment
                    
      net cash (used in) financing activities
                  -120,029,000  
      proceeds from issuance of series h redeemable convertible preferred stock, net of issuance costs
                    
      sale of redeemable convertible preferred stock
                    
      repurchase of redeemable convertible preferred stock
                    
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.